ConductScience.org, home

Paper41622930

[Mechanisms of Exosomes in Lung Cancer Bone Metastasis and Related Clinical Advances].

Yuan Y and 1 other. Zhongguo Fei Ai Za Zhi, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. [Mechanisms of Exosomes in Lung Cancer Bone Metastasis and Related Clinical Advances]. Papers, record 41622930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41622930

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Mechanisms of Exosomes in Lung Cancer Bone Metastasis and Related Clinical Advances].
PubMed
Journal
Zhongguo Fei Ai Za Zhi
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, English Abstract
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-07-06
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yuan YYuan
2Tang HHao

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ExosomesMajor topic
Lung NeoplasmsMajor topic
Bone NeoplasmsMajor topic
Humans
Animals
Tumor Microenvironment

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139625368FRK exerts oncogenic effects by targeting NQO2 via exosomal miR-9-3p to regulate mitochondrial function.FASEB J2024https://conductscience.org/library/papers/39625368PubMed
239494330New insights into non-small cell lung cancer bone metastasis: mechanisms and therapies.Int J Biol Sci2024https://conductscience.org/library/papers/39494330PubMed
338353469Exosome inhibition improves response to first-line therapy in small cell lung cancer.J Cell Mol Med2024https://conductscience.org/library/papers/38353469PubMed
433911215Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer.Nat Rev Clin Oncol2021https://conductscience.org/library/papers/33911215PubMed
532029601The biology, function, and biomedical applications of exosomes.Science2020https://conductscience.org/library/papers/32029601PubMed
639830759Inhibition of miR-9-3p facilitates ferroptosis by activating SAT1/p53 pathway in lung adenocarcinoma.Transl Lung Cancer Res2024https://conductscience.org/library/papers/39830759PubMed
738509870Hypoxic Exosomal circPLEKHM1-Mediated Crosstalk between Tumor Cells and Macrophages Drives Lung Cancer Metastasis.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38509870PubMed
833837261Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer.Sci Rep2021https://conductscience.org/library/papers/33837261PubMed
932783691Serum-Derived Exosomes-Mediated Circular RNA ARHGAP10 Modulates the Progression of Non-Small Cell Lung Cancer Through the miR-638/FAM83F Axis.Cancer Biother Radiopharm2022https://conductscience.org/library/papers/32783691PubMed
1034298673Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5.Cancers (Basel)2021https://conductscience.org/library/papers/34298673PubMed
1139582078[18F]FDG PET/CT performs better than CT in determining the bone biopsy site : randomized controlled clinical trial.Cancer Imaging2024https://conductscience.org/library/papers/39582078PubMed
1239817679Cancer statistics, 2025.CA Cancer J Clin2025https://conductscience.org/library/papers/39817679PubMed
1333680573Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment.Oncoimmunology2021https://conductscience.org/library/papers/33680573PubMed
1434215717Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.Cell Death Dis2021https://conductscience.org/library/papers/34215717PubMed
1532446904MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway.Cell Signal2020https://conductscience.org/library/papers/32446904PubMed
1634124049Lung Cancer Cell-Derived Exosomal let-7d-5p Down-Regulates OPRM1 to Promote Cancer-Induced Bone Pain.Front Cell Dev Biol2021https://conductscience.org/library/papers/34124049PubMed
1733913604Exosomes: Isolation, characterization, and biomedical applications.Cell Biol Int2021https://conductscience.org/library/papers/33913604PubMed
1835116241Transcriptome Sequencing reveals the expressed profiles of mRNA and ncRNAs and regulate network via ceRNA mediated molecular mechanism of lung adenocarcinoma bone metastasis in Xuanwei.Transl Cancer Res2021https://conductscience.org/library/papers/35116241PubMed
1939262456
Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 (CISD2), involved in lung adenocarcinoma bone metastasis via MYC activation, and associated with tumor immune infiltration.
Transl Cancer Res2024https://conductscience.org/library/papers/39262456PubMed
2032093031The Role of miR-21 in Osteoblasts-Osteoclasts Coupling In Vitro.Cells2020https://conductscience.org/library/papers/32093031PubMed

See all 67 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41622930

GET https://conductscience.org/api/papers/v1/41622930/references?page=2